The RNA N6-methyladenosine modification landscape of human fetal tissues

Nat Cell Biol. 2019 May;21(5):651-661. doi: 10.1038/s41556-019-0315-4. Epub 2019 Apr 29.

Abstract

A single genome gives rise to diverse tissues through complex epigenomic mechanisms, including N6-methyladenosine (m6A), a widespread RNA modification that is implicated in many biological processes. Here, to explore the global landscape of m6A in human tissues, we generated 21 whole-transcriptome m6A methylomes across major fetal tissues using m6A sequencing. These data reveal dynamic m6A methylation, identify large numbers of tissue differential m6A modifications and indicate that m6A is positively correlated with gene expression homeostasis. We also report m6A methylomes of long intergenic non-coding RNA (lincRNA), finding that enhancer lincRNAs are enriched for m6A. Tissue m6A regions are often enriched for single nucleotide polymorphisms that are associated with the expression of quantitative traits and complex traits including common diseases, which may potentially affect m6A modifications. Finally, we find that m6A modifications preferentially occupy genes with CpG-rich promoters, features of which regulate RNA transcript m6A. Our data indicate that m6A is widely regulated by human genetic variation and promoters, suggesting a broad involvement of m6A in human development and disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / genetics
  • Enhancer Elements, Genetic*
  • Epigenomics
  • Fetal Development / genetics*
  • Fetus*
  • Gene Expression Profiling
  • Gene Expression Regulation / genetics
  • Humans
  • Methylation
  • Polymorphism, Single Nucleotide / genetics
  • Promoter Regions, Genetic
  • RNA, Long Noncoding / genetics
  • Transcriptome / genetics

Substances

  • RNA, Long Noncoding
  • N-methyladenosine
  • Adenosine